288 related articles for article (PubMed ID: 28510269)
1. Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells.
Kryza T; Silva LM; Bock N; Fuhrman-Luck RA; Stephens CR; Gao J; Samaratunga H; ; Lawrence MG; Hooper JD; Dong Y; Risbridger GP; Clements JA
Mol Oncol; 2017 Oct; 11(10):1307-1329. PubMed ID: 28510269
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1.
Wang W; Mize GJ; Zhang X; Takayama TK
Int J Cancer; 2010 Feb; 126(3):599-610. PubMed ID: 19795418
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.
Ramsay AJ; Dong Y; Hunt ML; Linn M; Samaratunga H; Clements JA; Hooper JD
J Biol Chem; 2008 May; 283(18):12293-304. PubMed ID: 18308730
[TBL] [Abstract][Full Text] [Related]
4. Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer.
Seiz L; Kotzsch M; Grebenchtchikov NI; Geurts-Moespot AJ; Fuessel S; Goettig P; Gkazepis A; Wirth MP; Schmitt M; Lossnitzer A; Sweep FC; Magdolen V
Biol Chem; 2010 Apr; 391(4):391-401. PubMed ID: 20180634
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer.
Klokk TI; Kilander A; Xi Z; Waehre H; Risberg B; Danielsen HE; Saatcioglu F
Cancer Res; 2007 Jun; 67(11):5221-30. PubMed ID: 17545602
[TBL] [Abstract][Full Text] [Related]
6. Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1.
Fuhrman-Luck RA; Stansfield SH; Stephens CR; Loessner D; Clements JA
J Proteome Res; 2016 Aug; 15(8):2466-78. PubMed ID: 27378148
[TBL] [Abstract][Full Text] [Related]
7. Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.
Pereira BA; Lister NL; Hashimoto K; Teng L; Flandes-Iparraguirre M; Eder A; Sanchez-Herrero A; Niranjan B;
Biomaterials; 2019 Mar; 197():72-85. PubMed ID: 30641266
[TBL] [Abstract][Full Text] [Related]
8. Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer.
Lisle JE; Mertens-Walker I; Stephens CR; Stansfield SH; Clements JA; Herington AC; Stephenson SA
Exp Cell Res; 2015 Apr; 333(1):136-46. PubMed ID: 25724897
[TBL] [Abstract][Full Text] [Related]
9. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
[TBL] [Abstract][Full Text] [Related]
11. Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF).
Vancauwenberghe E; Noyer L; Derouiche S; Lemonnier L; Gosset P; Sadofsky LR; Mariot P; Warnier M; Bokhobza A; Slomianny C; Mauroy B; Bonnal JL; Dewailly E; Delcourt P; Allart L; Desruelles E; Prevarskaya N; Roudbaraki M
Mol Carcinog; 2017 Aug; 56(8):1851-1867. PubMed ID: 28277613
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.
Liao CP; Chen LY; Luethy A; Kim Y; Kani K; MacLeod AR; Gross ME
Endocr Relat Cancer; 2017 Apr; 24(4):157-170. PubMed ID: 28264911
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.
Gratio V; Beaufort N; Seiz L; Maier J; Virca GD; Debela M; Grebenchtchikov N; Magdolen V; Darmoul D
Am J Pathol; 2010 Mar; 176(3):1452-61. PubMed ID: 20056842
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.
Dong Y; Bui LT; Odorico DM; Tan OL; Myers SA; Samaratunga H; Gardiner RA; Clements JA
Endocr Relat Cancer; 2005 Dec; 12(4):875-89. PubMed ID: 16322328
[TBL] [Abstract][Full Text] [Related]
15. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
[TBL] [Abstract][Full Text] [Related]
16. KLK4T2 Is a Hormonally Regulated Transcript from the
Lundwall Å; Ylitalo EB; Wikström P; Brattsand M
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884832
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species-mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression.
Hsieh CL; Liu CM; Chen HA; Yang ST; Shigemura K; Kitagawa K; Yamamichi F; Fujisawa M; Liu YR; Lee WH; Chen KC; Shen CN; Lin CC; Chung LWK; Sung SY
Sci Rep; 2017 Aug; 7(1):9065. PubMed ID: 28831065
[TBL] [Abstract][Full Text] [Related]
18. Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.
Ting HJ; Deep G; Jain AK; Cimic A; Sirintrapun J; Romero LM; Cramer SD; Agarwal C; Agarwal R
Mol Carcinog; 2015 Sep; 54(9):730-41. PubMed ID: 24615813
[TBL] [Abstract][Full Text] [Related]
19. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
20. Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.
Brennen WN; Kisteman LN; Isaacs JT
Prostate; 2016 May; 76(6):552-64. PubMed ID: 26732992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
